Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net earnings	$ 488	$ 71
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation and amortization	162	176
Stock-based compensation	64	55
Deferred income taxes	(16)	(126)
Loss on divestiture	112	238
Pension settlement charge	0	171
Other	(9)	18
Changes in:
Receivables, net	71	(16)
Inventories, net	(54)	20
Prepaid expenses and other current assets	(28)	12
Accounts payable and accrued liabilities	(87)	(120)
Operating lease right-of-use assets and liabilities, net	1	0
Income taxes payable / prepaid	(17)	(144)
Net cash provided by operations	687	355
Investing activities:
Capital expenditures	(145)	(131)
Proceeds from divestiture, net of cash divested	128	17
Other	(1)	20
Net cash used for investing activities	(18)	(94)
Financing activities:
Notes and loans payable, net	50	61
Treasury stock purchased	(257)	0
Cash dividends paid to Clorox stockholders	(452)	(446)
Cash dividends paid to noncontrolling interests	(16)	0
Issuance of common stock for employee stock plans and other	30	3
Net cash used for financing activities	(645)	(382)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(2)	(26)
Net increase (decrease) in cash, cash equivalents and restricted cash	22	(147)
Cash, cash equivalents and restricted cash:
Beginning of period	207	368
End of period	$ 229	$ 221